Lecture Notes

**Lecture Coverage:**
- Epilepsy
- Anti-Epileptic Drugs
- Pharmacokinetic & Pharmacodynamic Properties of Anti-Epileptic Drugs

---
#### **Epilepsy**
- Recurrent Seizures from Episodic High-Frequency Neuronal Discharges

**Partial Seizures**
- Localized onset to specific brain areas

|                  Type                  | Description                                           |
| :------------------------------------: | ----------------------------------------------------- |
|             Simple Partial             | Unimpaired Consciousness                              |
|            Complex Partial             | Impaired Consciousness<br>(Temporal Lobe Involvement) |
| Partial w/<br>Secondary Generalization | Starts focally then spreads throughout the brain      |

**Generalized Seizures**
- Widespread brain activity from start
	- Usually impaired consciousness

|            Type             | Description                                                             |
| :-------------------------: | ----------------------------------------------------------------------- |
| Tonic-Clonic<br>(Grand Mal) | Sudden onset & unconsciousness<br>Limbs stiffen (Tonic) → Jerk (Clonic) |
|   Absence<br>(Petit Mal)    | Abrupt brief cessation of activity                                      |
|          Myoclonic          | Sudden brief muscle jerks                                               |
|           Atonic            | Sudden loss of muscle tone                                              |
|      Infantile Spasms       | Brief & Recurrent myoclonic jerks in<br>- Only in Infants               |


#### **Anti-Epileptic Drugs**
- Aim: To Inhibit Abnormal Neuronal Discharge through:
	- ↑ GABA<sub>A</sub> Action
	- ↓ Voltage-Gated Na<sup>+</sup> & Ca<sup>2+</sup> (P, Q & T) Channels

**GABA<sub>A</sub> Enhancing Drugs**

|                  Type                  |           Drug Examples           | Description                                                               |
| :------------------------------------: | :-------------------------------: | ------------------------------------------------------------------------- |
| GABA<sub>A</sub> Allosteric Modulators | Phenobarbitone<br>Benzodiazepines | [[Lecture 10.2A - (Neuropharmacology) Anxiolytic & Hypnotic Drugs\|Here]] |
|      GABA Transaminase Inhibitor       |            Vigabatrin             | Irreversible Inhibition<br>→ ↓ GABA Catabolism in Astrocytes & Synapses   |
**Voltage-Gated Na<sup>+</sup> Channel Inhibitors**

|                                                     Drug Examples                                                     | Description                                                                                            |
| :-------------------------------------------------------------------------------------------------------------------: | ------------------------------------------------------------------------------------------------------ |
| Carbamazepine<br>Oxcarzepine<br>Phenytoin<br><font color=lime>Valproate</font><br><font color=lime>Lamotrigine</font> | Use-Dependent Na<sup>+</sup> Channel Blockade<br>→ Blocks Excessive Firing while sparing Normal Firing |
**Voltage-Gated Ca<sup>2+</sup> Channel Inhibitors**

| Inhibited Ca²⁺ Channels |                                Drug Examples                                 | Description                                               |
| :---------------------: | :--------------------------------------------------------------------------: | --------------------------------------------------------- |
|           P,Q           | <font color=yellow>Gaba</font>pentin<br>Pre<font color=yellow>gaba</font>lin | Inhibits Rhythmic Thalamic Discharges in Absence Seizures |
|            T            |   <font color=lime>Valproate</font><br><font color=lime>Lamotrigine</font>   | ↓ Ca<sup>2+</sup>-dependent neurotransmitter exocytosis   |


#### **Pharmacokinetic & Pharmacodynamic Properties of Anti-Epileptic Drugs**
**Pharmacokinetic Properties**

|           Properties           | Drug                                         | Description                                                            |
| :----------------------------: | -------------------------------------------- | ---------------------------------------------------------------------- |
| <br><br>Drug-Drug Interactions | Phenobarbitone<br>Phenytoin<br>Carbamazepine | <br>P450 Enzyme Induction → ↑ Drug Metabolism → ↓ Drug Efficacy        |
|               ^                | Valproate                                    | P450 Enzyme Inhibition → ↓ Drug Metabolism → ↑ Drug Toxicity           |
|      Non-Linear Kinetics       | Phenytoin                                    | Disproportionate ↑ in Toxicity once Liver Capacity is Saturated        |
|       Therapeutic Window       | Phenytoin                                    | Narrow Therapeutic Window<br>→ Caution in Dosage Monitoring            |
|        Excretion Method        | Gabapentin<br>Pregabalin                     | Renal Excretion<br>→ Dose Adjustment in Patients with Renal Impairment |
**Pharmacodynamic Properties**
- Activity Spectrum

|                    Drugs                     | Indications                              |
| :------------------------------------------: | ---------------------------------------- |
|                  Valproate                   | Partial, Generalized & Absence Seizures  |
| Phenobarbitone<br>Phenytoin<br>Carbamazepine | <br>Partial & Tonic-Clonic Seizures only |
|                 Ethosuximide                 | Absence Seizures only                    |

- Side Effects

|             Side Effect              | Drugs                                                                                                                      |
| :----------------------------------: | -------------------------------------------------------------------------------------------------------------------------- |
| Sedation<br>Cognitive Impairment<br> | All Except Phenytoin                                                                                                       |
|  Dependence<br>Withdrawal Syndrome   | Benzodiazepines                                                                                                            |
|           <br><br>Toxicity           | Phenobarbitone: <abbr Title="Severe Rash in Han Chinese with HLA-B*1502">Stevens-Johnson Syndrome</abbr>, Aplastic Anaemia |
|                  ^                   | Phenytoin: Teratogenicity, Gum Hyperplasia& Bone Marrow Suppression                                                        |
|                  ^                   | Carbamazepine: Fatal in Overdose                                                                                           |
|                  ^                   | Valproate: Teratogenicity, Hepatoxicity                                                                                    |